Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
This negotiation mechanism fundamentally changes the financial model for drugs approaching but not yet past patent expiry
Ozempic
Two other pharmaceutical companies have their own oral GLP-1 drugs in the works: Orforglipron: Developed by Eli Lilly, its in Phase 3 clinical trials for treating type 2 diabetes and obesity, with an expected September 2025 completion
Please confirm with us before placing orders
Convenient dosing schedule for improved patient adherence
doi: 10.1016/j.apsb.2021.04.010 439 WangL.WangN.ZhangW.ChengX.YanZ.ShaoG.et al
US$ 23.15
US$ 23.58
US$ 28.94
US$ 23.60
US$ 29.41
US$ 22.18
US$ 24.13
